Regulation of Cell Signaling and Adhesion
细胞信号传导和粘附的调节
基本信息
- 批准号:6973916
- 负责人:
- 金额:$ 11.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-01 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:apoptosisastrocytesbiological signal transductioncell adhesioncell growth regulationcell migrationcell proliferationconfocal scanning microscopyflow cytometrygene expressiongene mutationgenetically modified animalsimmunocytochemistrylaboratory mouseleukocyte activation /transformationmessenger RNAmitogen activated protein kinasephosphoproteinsprotein bindingprotein protein interactionprotein structure functionspleenthymustissue /cell culturewestern blottings
项目摘要
DESCRIPTION (provided by applicant): The Mitogen Activated Protein Kinase/
Extracellular signal Regulated Kinase (MAPK/ERK) cascade controls cell growth
and survival and adhesion. I have used an expression-cloning strategy to
isolate a protein that blocks ERK/MAPK (p42/p44) signaling, PEA-15. PEA-15
impairs several ERK functions such as activation of transcription. PEA-15 binds
directly to ERK1/2 and co-localizes with it in the cytoplasm. While PEA-15
contains a death effector domain (DED) it affects apoptosis (programmed cell
death) in only a subset of cell types, specifically some fibroblasts and
astrocytes. In the PEA-15 null mouse, the most striking phenotype is a
lymphoproliferative syndrome affecting both B and T cells. There is also a
marked increase in hepatocyte proliferation and atrophy of the epidermis.
PEA-15 maps to human chromosome 1q21. This is a gene rich locus implicated in a
number of diseases, including acute myeloblastic leukemia and the skin disorder
Ichthyosis vulgaris. PEA-15 has been cloned as a gene upregulated in patients
with type II diabetes and appears to affect glucose metabolism in an undefined
manner. Finally, the 3' untranslated region of PEA-15 has been cloned as a
proto-oncogene, MAT-1, isolated from breast cancer cells. Hence, understanding
the mechanism, of PEA-15 regulation of ERK signaling may have direct clinical
relevance. The specific aims of this project are to: (1) Determine the residues
of PEA-15 that are necessary for ERK binding by mutational analysis; (2)
Determine the molecular mechanism by which PEA-15 affects ERK signaling; (3)
Analyze the expression of PEA-15 mRNA and protein; and (4) Examine the function
of PEA-15 expression on cell behavior in both cultured cells and cells derived
from PEA-15 null mice. This work will illuminate the functional significance of
PEA-15 and the molecular mechanism by which it acts. At the conclusion of these
studies we will better understand how alterations in cell adhesion, migration,
survival, and proliferation can be regulated by a novel player in cell
signaling events. Moreover, this work will elucidate the potential role of
PEA-15 in the pathogenesis of cancer and diabetes.
描述(由申请人提供):有丝分裂激活的蛋白激酶/
细胞外信号调节激酶(MAPK/ERK)级联控制细胞生长
以及生存和粘附。我已经使用了表达策略来
隔离蛋白质,该蛋白质阻断ERK/MAPK(P42/P44)信号传导,PEA-15。豌豆15
会损害几种ERK功能,例如转录的激活。豌豆15结合
直接到ERK1/2,并在细胞质中与其共定位。而豌豆15
包含一个死亡效应域(DED),它影响凋亡(程序性细胞)
死亡)仅在细胞类型的一部分中,特别是一些成纤维细胞和
星形胶质细胞。在Pea-15 null小鼠中,最引人注目的表型是
影响B和T细胞的淋巴增生性综合征。还有一个
表皮的肝细胞增殖和萎缩明显增加。
PEA-15地图至人类染色体1Q21。这是一个涉及的基因含量
包括急性骨髓白血病和皮肤疾病在内的疾病数量
鱼质福拉利。 PEA-15被克隆为患者上调的基因
患有II型糖尿病,似乎会影响不确定的葡萄糖代谢
方式。最后,豌豆15的3'未翻译区域被克隆为
从乳腺癌细胞中分离出的原始癌基因MAT-1。因此,理解
pea-15 ERK信号调节的机制可能具有直接的临床
关联。该项目的具体目的是:(1)确定残留物
通过突变分析所必需的PEA-15; (2)
确定PEA-15影响ERK信号传导的分子机制; (3)
分析PEA-15 mRNA和蛋白质的表达; (4)检查功能
培养细胞和衍生细胞中细胞行为的豌豆15表达
来自豌豆15无效的小鼠。这项工作将阐明
PEA-15及其作用的分子机制。在这些结束时
研究我们将更好地了解细胞粘附,迁移的改变,
生存和扩散可以由细胞中的新颖玩家调节
信号事件。此外,这项工作将阐明
PEA-15在癌症和糖尿病的发病机理中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joe William Ramos其他文献
Joe William Ramos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joe William Ramos', 18)}}的其他基金
RSK-2 regulates integrin-mediated adhesion and migration
RSK-2 调节整合素介导的粘附和迁移
- 批准号:
8144290 - 财政年份:2010
- 资助金额:
$ 11.17万 - 项目类别:
RSK-2 regulates integrin-mediated adhesion and migration
RSK-2 调节整合素介导的粘附和迁移
- 批准号:
8369905 - 财政年份:2010
- 资助金额:
$ 11.17万 - 项目类别:
RSK-2 regulates integrin-mediated adhesion and migration
RSK-2 调节整合素介导的粘附和迁移
- 批准号:
8328672 - 财政年份:2010
- 资助金额:
$ 11.17万 - 项目类别:
RSK-2 regulates integrin-mediated adhesion and migration
RSK-2 调节整合素介导的粘附和迁移
- 批准号:
8544478 - 财政年份:2010
- 资助金额:
$ 11.17万 - 项目类别:
RSK-2 regulates integrin-mediated adhesion and migration
RSK-2 调节整合素介导的粘附和迁移
- 批准号:
7987318 - 财政年份:2010
- 资助金额:
$ 11.17万 - 项目类别:
RSK-2 regulates integrin-mediated adhesion and migration
RSK-2 调节整合素介导的粘附和迁移
- 批准号:
8460455 - 财政年份:2010
- 资助金额:
$ 11.17万 - 项目类别:
相似国自然基金
腹侧海马星形胶质细胞参与焦虑症发病的机制研究
- 批准号:82371513
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
谱系特异的转录因子-代谢重编程诱导缺血皮质Sox2+星形胶质细胞去分化
- 批准号:82371402
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
星形胶质细胞糖代谢重编程介导Lactoferrin基因缺失引发的早期生长迟缓和认知障碍
- 批准号:32371037
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
NLRP3炎性小体介导星形胶质细胞与内皮细胞crosstalk在OSA认知损伤中的作用及机制研究
- 批准号:82371129
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
丘脑腹后外侧核中星形胶质细胞来源紧张性抑制电流在神经病理性疼痛中的作用及机制研究
- 批准号:82360235
- 批准年份:2023
- 资助金额:32.2 万元
- 项目类别:地区科学基金项目
相似海外基金
Elucidating the role of CHI3L1/YKL-40 in Alzheimer's disease
阐明 CHI3L1/YKL-40 在阿尔茨海默病中的作用
- 批准号:
10901027 - 财政年份:2023
- 资助金额:
$ 11.17万 - 项目类别:
MEK PATHWAY INHIBITION COMBINED WITH 5-AMINOLEVULINIC ACID-PHOTODYNAMIC THERAPY FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA
MEK 通路抑制联合 5-氨基酮戊酸光动力疗法治疗弥漫性中线胶质瘤
- 批准号:
10733440 - 财政年份:2022
- 资助金额:
$ 11.17万 - 项目类别:
Development of NLRP3 inhibitors for HIV-associated neuroinflammation
开发治疗 HIV 相关神经炎症的 NLRP3 抑制剂
- 批准号:
10548568 - 财政年份:2022
- 资助金额:
$ 11.17万 - 项目类别:
MEK PATHWAY INHIBITION COMBINED WITH 5-AMINOLEVULINIC ACID-PHOTODYNAMIC THERAPY FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA
MEK 通路抑制联合 5-氨基酮戊酸光动力疗法治疗弥漫性中线胶质瘤
- 批准号:
10536455 - 财政年份:2022
- 资助金额:
$ 11.17万 - 项目类别: